SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Citrin is a liver-type mitochondrial aspartate-glutamate carrier encoded by the SLC25A13 gene, and its deficiency causes adult-onset type II citrullinemia and neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD).
|
18162705 |
2007 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Screening for five prevalent mutations of SLC25A13 gene in Guangdong, China: a molecular epidemiologic survey of citrin deficiency.
|
25110155 |
2014 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Adult-onset citrullinemia (type II, CTLN2) has been attributed to citrin deficiency caused by mutations in the SLC25A13 gene.
|
17000460 |
2006 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Analysis of SLC25A13 mutations, identification of dysmorphic erythrocytes, hepatobiliary scintigraphic imaging and investigation of post-NICCD clinical presentations were performed in a citrin-deficient cohort comprised of 51 cases of children diagnosed with citrin deficiency in a Chinese pediatric center.
|
21424115 |
2011 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutation(s) of human SLC25A13 gene encoding a mitochondrial aspartate/glutamate carrier isoform 2 (AGC2), can lead to AGC2 deficiency, resulting in NICCD and an adult-onset fatal disease namely citrullinemia type II (CTLN2).
|
23067347 |
2012 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
SLC25A13 mutations cause two phenotypes, adult-onset type II citrullinemia and neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD).
|
21134364 |
2011 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Two of them have NICCD (neonatal intrahepatic cholestasis caused by citrin deficiency); three of them have CTLN2 (adult-onset type II citrullinemia).
|
31809266 |
2020 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Citrin deficiency was suspected, and genomic DNA analysis revealed a mutation (IVS16ins3kb) in SLC25A13, which encodes a mitochondrial aspartate-glutamate carrier protein.
|
26109823 |
2015 |
SLC25A13
|
0.700 |
Biomarker
|
disease |
BEFREE |
Two subjects did not present with NICCD, and were subsequently diagnosed later in life after their siblings presented with symptoms of citrin deficiency at one month of age and subsequently received a molecular diagnosis.
|
30181955 |
2018 |
SLC25A13
|
0.700 |
Biomarker
|
disease |
BEFREE |
Adult-onset type 2 citrullinaemia (CTLN2) is caused by a deficiency of the citrin protein encoded by the SLC25A13 gene.
|
12424587 |
2002 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Adult-onset type II citrullinemia (CTLN2), characterized by a liver-specific deficiency of urea cycle enzyme, argininosuccinate synthetase, is caused by mutations in SLC25A13 that encodes a calcium binding mitochondrial solute carrier protein, citrin.
|
12602510 |
2002 |
SLC25A13
|
0.700 |
Biomarker
|
disease |
BEFREE |
Citrin deficiency (CD) is an autosomal recessive disorder with SLC25A13 as causative gene that encodes citrin, the liver-type aspartate/glutamate carrier isoform 2 (AGC2).
|
22095253 |
2011 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Inspissated bile syndrome in an infant with citrin deficiency and congenital anomalies of the biliary tract and esophagus: identification and pathogenicity analysis of a novel SLC25A13 mutation with incomplete penetrance.
|
25216257 |
2014 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A genetic analysis of solute carrier family 25, member 13 revealed the presence of a homozygous 851del4 mutation, and a diagnosis of citrin deficiency was made.
|
30591617 |
2019 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Because CTLN2 has been associated with hepatocellular carcinoma (HCC) and may be involved in hepatocarcinogenesis, the objective of this study was to assess the frequency of SLC25A13 mutations in patients with non-viral HCC.
|
21470889 |
2011 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
oligonucleotide array CGH identified intragenic exonic deletions in 2 cases: a heterozygous single-exon deletion of 4.5 kb in the SLC25A13 gene [solute carrier family 25, member 13 (citrin)] in an individual with citrin deficiency and a homozygous 10.5-kb deletion of exons 13-17 in the ABCB11 gene [PFIC2, ATP-binding cassette, sub-family B (MDR/TAP), member 11] in a patient with progressive familial intrahepatic cholestasis.
|
18487280 |
2008 |
SLC25A13
|
0.700 |
Biomarker
|
disease |
BEFREE |
In contrast, the estimated carrier frequencies for SLC25A13, which causes citrin deficiency, were much higher compared with the incidence rate.
|
30887117 |
2019 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These methods have shown that more than 90% of the patients diagnosed as suffering from CTLN2 by enzymatic analysis carry SLC25A13 mutations in both alleles, indicating that CTLN2 is caused by citrin deficiency.
|
12111366 |
2002 |
SLC25A13
|
0.700 |
Biomarker
|
disease |
BEFREE |
Adult-onset type II citrullinemia (CTLN2) is characterized by a liver-specific argininosuccinate synthetase deficiency caused by a deficiency of the citrin protein encoded by the SLC25A13 gene.
|
11281457 |
2001 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Diagnosis of NICCD was established before transplantation, and donor evaluation included mutation in the SLC25A13 gene for exclusion of individuals with citrin deficiency citrullinemia.
|
19413723 |
2010 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency.
|
16059747 |
2005 |
SLC25A13
|
0.700 |
Biomarker
|
disease |
BEFREE |
SLC25A13 (citrin or aspartate-glutamate carrier 2) is located in the mitochondrial membrane in the liver and its genetic deficiency causes adult-onset type II citrullinemia (CTLN2).
|
25533124 |
2015 |
SLC25A13
|
0.700 |
Biomarker
|
disease |
BEFREE |
Identification of the genes responsible for adult-onset type II citrullinemia (CTLN2) and citrin protein function have enhanced our understanding of citrin deficiency.
|
31255436 |
2019 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This study aims to investigate the effect of a novel missense mutation on the aspartate/glutamate carrier (AGC) function of citrin protein, and to explore the aberrant transcript from c.615+5G>A in the same CD infant.
|
24586645 |
2014 |
SLC25A13
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
SLC25A13 gene mutations cause citrin deficiency, which leads to neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD).
|
20927635 |
2011 |